Gastric sleeve vs bypass: what the ten-year evidence says about the choice

How to choose: bypass or sleeve?

Set side by side, the two operations differ on five practical points that shape daily life afterwards.

Gastric sleeve	Gastric bypass
Stomach reshaped into a tube	Small pouch joined to the bowel
One to two hours in theatre	Two and a half to four hours
Reflux more likely later	Reflux usually improves
Narrower supplement regime	Lifelong, broader supplements
Often converted to bypass	Rarely converted

What is gastric bypass?

Gastric bypass creates a small pouch from the upper stomach and joins it directly to the small intestine. The rest of the stomach and the first stretch of bowel are bypassed: food no longer travels through them, although they keep their blood supply and continue to produce digestive secretions. The volume available for a meal becomes very small, and the shortened route changes the hormonal signals sent by the gut, which explains a good part of the effect on appetite and on blood glucose. Calorie malabsorption plays a smaller role in a standard bypass than patient leaflets often suggest, though the reduced absorption of micronutrients is very real.

The operation is performed laparoscopically and takes between two and a half and four hours. Expectations about the hospital stay have shifted. Enhanced recovery protocols, which allow patients to drink and eat early and to get moving quickly, have been shown to be safe in bariatric surgery: pooled trial data show fewer episodes of postoperative vomiting with these pathways than with conventional care, alongside shorter stays and lower costs (Hu et al., 2026). Where a medical travel programme keeps you in hospital or nearby for longer, that reflects observation before the flight home rather than a surgical requirement.

What commits you after a bypass is not the operating theatre but everything that follows. Eating resumes in stages, from liquids through to solids, in very small portions spread across the day. Physical activity is rebuilt gradually, starting with walking. And vitamin and mineral supplementation becomes a lifelong treatment, because the reconstruction reduces the absorption of several nutrients. That is the condition for the operation to keep serving you well ten or twenty years on.

What is sleeve gastrectomy?

Sleeve gastrectomy permanently removes roughly 80% of the stomach, including the greater curvature, leaving a narrow vertical tube still connected to the intestine in the usual way. The digestive route is not diverted, and that is the major difference from a bypass. The volume you can eat at one sitting falls sharply, and removing the fundus lowers production of ghrelin, the hormone associated with hunger.

The procedure is shorter, one to two hours as a rule, and technically less demanding. Eating afterwards follows the same logic of small, frequent portions. Supplements are still needed, though they cover a narrower range of nutrients than a bypass demands. The sleeve does not leave digestion untouched, however: gastric emptying speeds up, the hormonal balance changes, and iron or vitamin B12 deficiencies develop in a proportion of patients.

What the choice really turns on

Start with the criterion patients underestimate most, because it is the one you can answer yourself: whether lifelong follow-up is realistic for you. A bypass asks for broader supplementation, blood tests at set intervals and sustained vigilance about deficiencies, for decades. Someone who moves often, works shifts, or struggles to keep appointments is not a worse patient, but that pattern of life sits better with a sleeve. Being honest about this in clinic changes the recommendation more often than people expect.

Reflux is the criterion your surgeon will weigh most heavily. A sleeve tends to worsen or trigger it, while a bypass often improves it. Daily heartburn before surgery, or a hiatus hernia of any size, therefore points towards a bypass. This is where the long-term evidence is clearest, and we return to it below.

Type 2 diabetes comes next. A bypass acts faster on blood glucose in the early months, which remains an argument where glycaemic control is poor, even though the difference in remission rates has faded by the ten-year mark.

A very high BMI often leads a team to start with a sleeve, precisely because it is shorter and less demanding on the body. A bypass can be added later if needed, giving a two-stage strategy. Similar reasoning applies to older patients and to anyone with a history of abdominal surgery or inflammatory bowel disease, where a simpler operation limits the surgical risk. Whichever way the balance falls, the decision belongs to a multidisciplinary team that includes a surgeon, a dietitian, a psychologist and your GP, and asking for a second opinion has never harmed anyone.

What impacts on weight loss?

The two randomised trials that compared the operations head to head over ten years produce a more nuanced picture than the older figures suggest. In the Swiss SM-BOSS trial, excess BMI loss reached 60.6% after sleeve and 65.2% after bypass on an intention-to-treat basis, a difference that did not reach statistical significance. Analysed per protocol, counting only patients who kept the operation they were assigned, the same trial found 56.1% against 65.9%, and that gap was significant. Total weight loss did not differ either way, at 25.5% against 27.7% (Kraljevic et al., 2025). The two readings of one trial explain much of the disagreement you will find between sources.

A recent meta-analysis pooling every cohort and trial followed for at least ten years reaches the same verdict of near parity on the metabolic outcomes. Remission of type 2 diabetes did not differ between the procedures (risk ratio 0.88, 95% CI 0.67 to 1.15), nor did remission of dyslipidaemia (risk ratio 0.84, 95% CI 0.64 to 1.09), and the trend favouring bypass for hypertension did not reach significance (Chouky Kamar et al., 2026).

After sleeve surgery

The largest real-world dataset published to date, covering patients treated between 2018 and 2024, records total weight loss of 24.4% at one year and 22.0% at three years after a sleeve (Brown et al., 2026). Obesity-related conditions improve along the same curve, with remission of diabetes, hypertension and sleep apnoea that is common without being universal. Regaining part of the lost weight after the second year is an expected pattern rather than a sign of failure, as our guide to life after a gastric sleeve sets out.

After bypass surgery

In the same cohort, bypass produced 29.8% total weight loss at one year and 28.4% at three years (Brown et al., 2026). The gap with the sleeve is therefore more visible over the first three years than in the long term. As with a sleeve, the outcome depends closely on what changes in daily life: diet, physical activity and the regularity of follow-up account for a large share of the variation between patients.

Side effects of sleeve and bypass surgery

Side effects after sleeve

Most side effects of a sleeve are temporary. Hair shedding frequently appears in the months after surgery, driven by rapid weight loss and reduced intake, and usually settles once eating stabilises. Constipation is common, given how much less food and fluid you take in. Iron and B-group vitamin deficiencies can develop and justify supplementation, checked by regular blood tests.

Side effects after bypass surgery

Changes in bowel habit are the most frequent complaint after a bypass: loose stools or diarrhoea, wind and bloating. Dumping syndrome, the flush of sweating, palpitations and fatigue that follows a sugary meal reaching the intestine too quickly, affects many patients and forces a rethink of how meals are put together. The nutritional demands are greater than after a sleeve, with deficiencies to watch for in iron, vitamin B12, vitamins D, B1, B6 and B9, zinc, selenium and protein. Supplements and periodic blood tests are not optional here.

Late complications after sleeve or bypass surgery

Complications after a sleeve

Gastro-oesophageal reflux is the characteristic late complication of a sleeve. The mechanism is not the loss of a valve, since the lower oesophageal sphincter stays where it is. Higher pressure inside a stomach that has become a narrow tube, combined with the altered angle between oesophagus and stomach, is what allows stomach contents back up. Ten-year follow-up shows new-onset reflux significantly more often after a sleeve than after a bypass (Kraljevic et al., 2025).

It is also the leading reason for further surgery, at proportions that weigh heavily in the choice. In SM-BOSS, 29.9% of sleeve patients were converted to a bypass beyond ten years, for insufficient weight loss or for reflux, against 5.5% in the bypass group (Kraljevic et al., 2025). The ten-year meta-analysis reports the same excess of conversions on the sleeve side (Chouky Kamar et al., 2026).

Complications after a bypass

Marginal ulcer is the late complication most often cited after a bypass. It forms at the join between the gastric pouch and the intestine, with smoking and anti-inflammatory drugs as the principal risk factors. It shows itself through upper abdominal pain, nausea and vomiting, and it responds to medical treatment in most cases when caught early.

Bowel obstruction is the other late complication of bypass surgery. It occurs when the passage of food is blocked, most often by an internal hernia forming in a space left by the surgical reconstruction, sometimes by a narrowing of the join or by adhesions. The signs are severe abdominal pain, vomiting, absent bowel movements and a distended abdomen. This situation needs surgical assessment without delay, which is why severe abdominal pain after a bypass, even years later, means a trip to A&E rather than a scheduled appointment.

Sleeve gastrectomy has become the more commonly performed operation, helped by a shorter procedure, preserved anatomy and a simpler recovery. Ulcers, internal hernias and obstructions are rarer after it than after a bypass. The ten-year reading completes that picture rather than contradicting it: the sleeve carries more reflux and a much higher chance of later conversion, while the bypass asks for a heavier nutritional discipline from the outset. Neither technique wins on every criterion, and that is exactly why the choice is built around your own file.

/wp-content/uploads/2023/08/post-info-en-story-chirurgie-bariatrique.mp4

Where weight loss medication fits

Since semaglutide and then tirzepatide became widely available, a fair question is whether an injection could replace an operation altogether. A real-world study of 44,025 adults with a BMI of 35 or above, treated across two urban health systems between 2018 and 2024, gives the order of magnitude. Counting only patients who stayed on their medication continuously for at least a year, total weight loss reached 8.8% with semaglutide at three years and 11.9% with tirzepatide at two years. The surgical arms of the same study lost substantially more (Brown et al., 2026).

That does not make the medicines irrelevant. They suit situations where surgery is not indicated or not wanted, and they have a place before or after an operation. What the figures show is that, for someone eligible for both, the scale of weight loss is not comparable.

Frequently asked questions

Is a sleeve reversible?
No, because the removed portion of stomach cannot be put back. It is convertible, though: a surgeon can turn it into a bypass, which happens to a substantial minority of patients over the long term. A bypass is not reversed in routine practice either, even if the reconstruction is theoretically undoable.

How long before I can go back to work?
It depends on the operation, the nature of your job and how you recover. Desk work resumes earlier than anything involving lifting, and a bypass usually calls for more time than a sleeve. The date is set with your surgeon at the postoperative check rather than pencilled in beforehand.

What happens if I do not lose enough weight?
This is a documented and treatable situation. The first step is to review nutrition and eating patterns with your follow-up team. Depending on the case, medication, a revision of the reconstruction or conversion to another technique may be discussed. Regaining some of the lost weight after the second year is not on its own a reason to reoperate.

Can I choose between sleeve and bypass myself?
Your preference matters and should be heard, particularly on how much follow-up you feel able to sustain. It does not replace clinical assessment: reflux, a hiatus hernia, diabetes or previous abdominal surgery can rule one of the options out. The final decision rests with the multidisciplinary team once your file has been reviewed in full.

The safest route to a comparison that fits your own situation is to put your complete medical history in front of a bariatric surgeon and ask the awkward questions, including what happens if things do not go to plan.

Sources

Brown, A., Patel, S. S., Kozato, A., Orandi, B. J., Massie, A., Vu, A. H., Somoza, E., Mei, T., Desai, S., Zhang, D. S., Segev, D., Welcome, A. U., Ren-Fielding, C., Parikh, M., & Chhabra, K. R. (2026). Real-world effectiveness of semaglutide and tirzepatide compared with bariatric surgery. Obesity, 34(8), 1583-1591. https://doi.org/10.1002/oby.70246

Chouky Kamar, M., Astudillo Coello, P. E., Rodrigues Dos Santos, A. V., & Leite Melo, S. (2026). Ten-year follow-up for sleeve gastrectomy versus Roux-en-Y gastric bypass: A systematic review and meta-analysis. Obesity Surgery, 36(5), 2625-2633. https://doi.org/10.1007/s11695-026-08630-4

De Luca, M., Shikora, S., Eisenberg, D., Angrisani, L., Parmar, C., Alqahtani, A., Aminian, A., Aarts, E., Brown, W., Cohen, R. V., Di Lorenzo, N., Faria, S. L., Goodpaster, K. P. S., Haddad, A., Herrera, M., Rosenthal, R., Himpens, J., Iossa, A., Kermansaravi, M., … Kothari, S. N. (2024). Scientific evidence for the updated guidelines on indications for metabolic and bariatric surgery (IFSO/ASMBS). Obesity Surgery, 34(11), 3963-4096. https://doi.org/10.1007/s11695-024-07370-7

Hu, F., Yang, Y., Sun, Y., Sun, L., Wang, X., Jia, Z., Gao, N., & Liu, N. (2026). The value of enhanced recovery after surgery in bariatric care: A systematic review and trial sequential meta-analysis confirming reduced length of stay, costs, and nursing-sensitive complications. Surgery for Obesity and Related Diseases, 22(9), 1035-1043. https://doi.org/10.1016/j.soard.2026.05.005

Kraljevic, M., Süsstrunk, J., Wölnerhanssen, B. K., Peters, T., Bueter, M., Gero, D., Schultes, B., Poljo, A., Schneider, R., & Peterli, R. (2025). Long-term outcomes of laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: The SM-BOSS randomized clinical trial. JAMA Surgery, 160(4), 369-377. https://doi.org/10.1001/jamasurg.2024.7052